TEVA logo

TEVA EBITDA

Latest reported-$19.00M
TEVA Quarterly EBITDA ($22.80M → -$19.00M)
High-resolution chart · PNG

TEVA ebitda history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Teva Pharmaceutical Industries Limited American Depositary Shares EBITDA — Quarterly (USD)
Period endingEBITDA (USD)
-19,000,000
877,000,000
632,000,000
1,104,000,000
657,000,000
953,000,000
1,162,000,000
207,000,000
246,000,000
55,000,000
1,517,000,000
627,000,000
970,000,000
803,000,000
-586,000,000
739,000,000
1,009,000,000
-369,000,000
231,000,000
1,039,000,000
898,000,000
810,000,000
1,117,000,000
-3,961,000,000
554,000,000
590,000,000
1,116,000,000
332,000,000
-194,000,000
577,000,000
-2,728,000,000
1,118,000,000
465,000,000
2,032,000,000
-12,580,000,000
1,414,000,000
-5,163,000,000
1,375,000,000
-101,000,000
1,342,000,000
671,000,000
1,470,000,000
1,447,000,000
1,630,000,000
1,648,000,000
1,084,000,000
1,298,000,000
1,473,000,000
1,299,000,000
1,376,000,000
911,000,000
1,431,000,000
-186,000,000
1,344,000,000
692,000,000
352,000,000
1,391,000,000
1,447,000,000
942,000,000
1,282,000,000
-373,000,000
1,133,000,000
1,024,000,000
1,447,000,000
1,308,000,000
1,069,000,000
440,000,000
1,007,000,000
959,000,000
709,000,000
-704,000,000
777,000,000
760,000,000
805,000,000
801,000,000
765,000,000
767,000,000
583,000,000
526,800,000
833,700,000
805,100,000
393,000,000
412,850,000
312,200,000
308,600,000
386,400,000
335,400,000
317,700,000
297,100,000
850,800,000
306,700,000
197,100,000
281,900,000
179,300,000
182,600,000
121,600,000
111,600,000
108,200,000
126,890,000
99,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.